Recent research of efficient chiral synthesis technologies reveals potential uses in API manufacturing. The majority of small-molecule drugs in development today contain chiral centers, and according ...
Nanoscale catalysts and engineered nanoparticles may have a big impact on small-molecule pharmaceuticals. Materials science, while often associated with industries other than bio/pharmaceuticals, also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results